- Home
- HCI vs PLSE Comparison
HCI vs PLSE Comparison
Compare HCI & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HCI | PLSE |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 3.6B |
| IPO Year | 2008 | 2015 |
Fundamental Metrics
Financial Performance| Metric | HCI | PLSE |
|---|---|---|
| Price | $190.04 | $53.84 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $250.00 | $67.67 |
| AVG Volume (30 Days) | 141.6K | ★ 365.7K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | ★ 0.84% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 17.48 | N/A |
| Revenue | ★ $900,946,000.00 | N/A |
| Revenue This Year | $9.33 | $480.71 |
| Revenue Next Year | $9.99 | $177.98 |
| P/E Ratio | $10.86 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $144.75 | $12.56 |
| 52 Week High | $208.80 | $58.94 |
Technical Indicators
Market Signals| Indicator | HCI | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 44.27 | 51.90 |
| Support Level | $172.95 | $49.01 |
| Resistance Level | $196.13 | $56.54 |
| Average True Range (ATR) | 5.91 | 3.87 |
| MACD | -1.83 | 0.18 |
| Stochastic Oscillator | 24.35 | 40.32 |
Price Performance
Historical ComparisonAbout HCI HCI Group Inc.
HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property & Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap). Both HCPCI and TypTap are authorized to underwrite various homeowners' property and casualty insurance products and allied lines business in the state of Florida and other states. The operating segments of the group are insurance operations, TypTap Group, reciprocal exchange operations, real estate operations, and corporate and other. It derives key revenue from the HCPCI Insurance operation segment.
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.